Fortress Biotech, Inc. (FBIOP) Operating cash flow 2016–2025
Fortress Biotech, Inc. (FBIOP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$65.8MFY2025 · since FY2016: -$45.8M → -$65.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.8M | +18.0% |
| FY2024 | -$80.2M | +37.5% |
| FY2023 | -$128.2M | +28.5% |
| FY2022 | -$179.4M | -53.9% |
| FY2021 | -$116.5M | -39.3% |
| FY2020 | -$83.7M | +11.9% |
| FY2019 | -$95.0M | +3.9% |
| FY2018 | -$98.8M | -21.6% |
| FY2017 | -$81.3M | -77.5% |
| FY2016 | -$45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net incomeFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating incomeFBIOP Operating marginFBIOP Free cash flowFBIOP Capital expendituresFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Total liabilitiesFBIOP Shareholders’ equityFBIOP overview →